Victor Bazan

Victor Bazan

Auto-generated profile, based on publicly available information

Victor Bazan

Heart Institute (iCOR), Germans Trias i Pujol University Hospital

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2025 in EP Europace
Verified
Journal Article
Open access
AAArash Arya
Arash Arya
LBLuigi Di Biase
Luigi Di Biase
VBVictor Bazán
Victor Bazán
ABAntonio Berruezo
Antonio Berruezo
ADAndre D’Avila
Andre D’Avila
GZGiulio Zucchelli
Giulio Zucchelli
Epicardial access during electrophysiology procedures offers valuable insights and therapeutic options for managing ventricular arrhythmias (VAs). The current clinical consensus statement on epicardial VA ablation aims to provide clinicians with a comprehensive understanding of this complex clinical scenario. It offers structured advice and a systematic approach to patient management. Specific sections are devoted to anatomical considerations, criteria for epicardial access and mapping evaluation, methods of epicardial access, management of complications, training, and institutional requirements for epicardial VA ablation. This consensus is a joint effort of collaborating cardiac electrophysiology societies, including the European Heart Rhythm Association, the Heart Rhythm Society, the Asia Pacific Heart Rhythm Society, the Latin American Heart Rhythm Society, and the Canadian Heart Rhythm Society.

1 May 2024 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Closed access
PDF file
DMDaina Martínez-Falguera
Daina Martínez-Falguera
JAJúlia Aranyó
Júlia Aranyó
ATAlbert Teis
Albert Teis
GFGemma Ferrer-Curriu
Gemma Ferrer-Curriu
MMMarta Monguió-Tortajada
Marta Monguió-Tortajada
Carolina Gálvez-MontónCarolina Gálvez-Montón
Carolina Gálvez-Montón
BACKGROUND: Sacubitril/valsartan (Sac/Val) is superior to angiotensin-converting enzyme inhibitors in reducing the risk of heart failure hospitalization and cardiovascular death, but its mechanistic data on myocardial scar after myocardial infarction (MI) are lacking. The objective of this work was to assess the effects of Sac/Val on inflammation, fibrosis, electrophysiological properties, and ventricular tachycardia inducibility in post-MI scar remodeling in swine. METHODS: After MI, 22 pigs were randomized to receive β-blocker (BB; control, n=8) or BB+Sac/Val (Sac/Val, n=9). The systemic immune response was monitored. Cardiac magnetic resonance data were acquired at 2-day and 29-day post MI to assess ventricular remodeling. Programmed electrical stimulation and high-density mapping were performed at 30-day post MI to assess ventricular tachycardia inducibility. Myocardial samples were collected for histological analysis. RESULTS: Compared with BB, BB+Sac/Val reduced acute circulating leukocytes ( P =0.009) and interleukin-12 levels ( P =0.024) at 2-day post MI, decreased C-C chemokine receptor type 2 expression in monocytes ( P =0.047) at 15-day post MI, and reduced scar mass ( P =0.046) and border zone mass ( P =0.043). It also lowered the number and mass of border zone corridors ( P =0.009 and P =0.026, respectively), scar collagen I content ( P =0.049), and collagen I/III ratio ( P =0.040). Sac/Val reduced ventricular tachycardia inducibility ( P =0.034) and the number of deceleration zones ( P =0.016). CONCLUSIONS: After MI, compared with BB, BB+Sac/Val was associated with reduced acute systemic inflammatory markers, reduced total scar and border zone mass on late gadolinium-enhanced magnetic resonance imaging, and lower ventricular tachycardia inducibility.

1 January 2016 in Archivos de Bronconeumología
Verified
Journal Article
Closed access
NGNuria Grau
Nuria Grau
VBVictor Bazan
Victor Bazan
MKMohamed Kallouchi
Mohamed Kallouchi
DRDiego Rodriguez
Diego Rodriguez
CECristina Estirado
Cristina Estirado
JMJulio Marti-Almor
Julio Marti-Almor

Verified
Journal Article
Open access
PDF file
AAAmine El Amrani
Amine El Amrani
XVXavier Viñolas
Xavier Viñolas
MAMiguel Angel Arias
Miguel Angel Arias
VBVictor Bazan
Victor Bazan
PVpilar valdovinos
pilar valdovinos
JAJosep M Alegret
Josep M Alegret
Background: Antiarrhythmic drugs (AADs) are frequently initiated in patients with persistent atrial fibrillation (AF) prior to electrical cardioversion (ECV), achieving pharmacological cardioversion (PCV) in some cases. Little is known about the mode of cardioversion and the effect of the type of AAD used in the maintenance of sinus rhythm (SR). Methods: From three national surveys of patients with persistent AF referred for ECV, we selected those who were pre-treated with AADs (amiodarone or group Ic AADs). We analyzed the effect of the type of cardioversion (pharmacological vs. electrical) and the AAD used in the maintenance of SR at three months. Results: Among the 665 patients selected, 151 had a successful PCV prior to the planned ECV. In the remaining 514 patients, 460 had a successful ECV. A successful PCV was related to a higher rate of SR maintenance than a successful ECV (77.9% vs. 57.5%; p < 0.0001). After a successful PCV, the maintenance of SR was identical in those patients treated with amiodarone and those treated with group Ic AADs (77.4% vs. 77.5%; p = 0.99), whereas after a successful ECV, amiodarone was clearly superior to group Ic AADs (61.3% vs. 43.0%; p = 0.001). Considering patients with successful PCV and ECV together, PCV was an independent factor related to the maintenance of SR. Conclusions: In patients with persistent AF, successful PCV selects a subgroup with a high probability of maintenance of SR. With regard to drugs, amiodarone was superior to group Ic AADs in patients with ECV, whereas in PCV, no differences were observed.

1 January 2021 in The American Journal of Cardiology
Verified
Journal Article
Closed access
VBVictor Bazan
Victor Bazan
IVIgnacio Vicente
Ignacio Vicente
LLLourdes Lozano
Lourdes Lozano
RVRoger Villuendas
Roger Villuendas
MGMarta González
Marta González
ABAntoni Bayés-Genís
Antoni Bayés-Genís

1 December 2014 in International Journal of Cardiology
Verified
Journal Article
Closed access
EVErmengol Valles
Ermengol Valles
VBVictor Bazan
Victor Bazan
MCMiguel Cainzos-Achirica
Miguel Cainzos-Achirica
MJMiguel Eduardo Jáuregui
Miguel Eduardo Jáuregui
BBBegoña Benito
Begoña Benito
JMJulio Marti-Almor
Julio Marti-Almor